Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market
AstraZeneca and Ionis Prescription drugs drug eplontersen, model identify Wainua, failed a Part 3 check in cardiomyopathy attributable to transthyretin ...
Tag: Ionis
In Crowded Market for a Rare Disease, Ionis Bets Patients Will Switch to Its New First-in-Class Drug
As with most rare diseases, the market for hereditary angioedema drugs is small. It’s also relatively crowded, served by several ...
Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test
An Ionis Pharmaceuticals drug in development for Angelman syndrome has mid-stage clinical trial results showing improvement across a range of ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!